Lakewood-Amedex Biotherapeutics Inc. (LABT) SEC Filings

Lakewood-Amedex Biotherapeutics Inc. (LABT) SEC EDGAR filings (10-Q, DEF 14A, 8-K, S-1, S-1/A), newest first; latest 10-Q filed 2026-08-14. Every filing links to the canonical SEC document. First-party data.

SEC filings — source: EDGAR

Filed	Form	Title
2026-08-14	10-Q	10-Q filed 2026-08-14 by Lakewood-Amedex Biotherapeutics Inc.
2026-08-10	DEF 14A	DEF 14A filed 2026-08-10 by Lakewood-Amedex Biotherapeutics Inc.
2026-07-15	8-K	8-K filed 2026-07-15 by Lakewood-Amedex Biotherapeutics Inc.
2026-06-17	8-K	8-K filed 2026-06-17 by Lakewood-Amedex Biotherapeutics Inc.
2026-05-22	10-Q	10-Q filed 2026-05-22 by Lakewood-Amedex Biotherapeutics Inc.
2026-05-01	S-1	S-1 filed 2026-05-01 by Lakewood-Amedex Biotherapeutics Inc.
2026-04-28	8-K	8-K filed 2026-04-28 by Lakewood-Amedex Biotherapeutics Inc.
2026-04-06	S-1/A	S-1/A filed 2026-04-06 by Lakewood-Amedex Biotherapeutics Inc.
2026-04-01	S-1/A	S-1/A filed 2026-04-01 by Lakewood-Amedex Biotherapeutics Inc.
2026-03-11	S-1/A	S-1/A filed 2026-03-11 by Lakewood-Amedex Biotherapeutics Inc.
2026-02-13	S-1/A	S-1/A filed 2026-02-13 by Lakewood-Amedex Biotherapeutics Inc.
2026-02-05	S-1/A	S-1/A filed 2026-02-05 by Lakewood-Amedex Biotherapeutics Inc.
2026-01-09	S-1	S-1 filed 2026-01-09 by Lakewood-Amedex Biotherapeutics Inc.

LABT overview · LABT earnings · LABT financials · LABT KPIs · LABT investor relations · LABT ownership · LABT peers

Data sourced from U.S. SEC EDGAR. Not personalized investment advice.